Press Releases

Mallinckrodt plc a leading global specialty biopharmaceutical company announced the results from three Mallinckrodt-sponsored retrospective analyses providing health economic insights for the use of H.P. Acthar Gel (repository corticotropin injection; RCI) in three distinct patient populations:...

Australia’s largest and most successful biotechnology company, CSL, will officially celebrate 100 years of operation on 25th April 2016. World pharma today/Press releases /-Originally named the ‘Commonwealth Serum Laboratories’, CSL was established in 1916 by the...

AstraZeneca and its global biologics research and development arm, MedImmune, today announced an integrated genomics initiative to transform drug discovery and development across its entire research and development pipeline. The initiative includes new collaborations with Human...

Novo Nordisk announced that it plans to invest more than 100 million euros in production facilities at its site in Chartres, France. The expansions will help Novo Nordisk meet the increasing worldwide demand for its diabetes medicines. ...

CPhI Istanbul 2016, organised by UBM EMEA, returns for the third consecutive year to Turkey, co-located with InnoPack, ICSE and P-MEC. The four-in-one event will take place at the Istanbul Congress Center (ICC).   Turkey, from...

Baxter International Inc announced it has received Marketing Authorization from the Competent Authorities in the United Kingdom and Denmark for NUMETA G13E 300 mL, a parenteral (intravenous) nutrition (PN) product. These national approvals are the first of 20 European...

Enhanced Mechanism Of Angiogenesis Inhibition And Anti-Tumor Activity In Renal Cell Carcinoma Investigated World pharma today/Press releases /-Eisai Co Ltd. announced that it has presented the results of non-clinical research investigating the combination of Eisai's in-house...